RecruitingNot ApplicableNCT04636892

Evaluating Infrasonic Hemodynography

Clinical Correlation of a Novel Wearable Sensor to Detect Cardiovascular Mechanical and Electrical Properties Through Infrasonic Hemodynography


Sponsor

Scripps Health

Enrollment

25 participants

Start Date

Jan 4, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

This comparative diagnostic accuracy study will determine the accuracy of a noninvasive wearable infrasonic sensor to detect the mechanical, electrical, and hemodynamic function of the cardiovascular system.


Eligibility

Inclusion Criteria2

  • Normal Sinus Rhythm
  • LV systolic function \>53%

Exclusion Criteria6

  • \. Known history of carotid artery disease
  • \. Moderate or greater valvular disease in Group 1
  • \. Other implantable devices (pacemaker, ICD, CardioMems, TENS unit, continuous glucose monitors, etc)
  • \. Active arrhythmia
  • \. Reduced Ejection Fraction (\< 35%) other than Group 4
  • \. Hearing loss

Interventions

OTHERMindMics earbud

Novel noninvasive wearable infrasound sensor


Locations(1)

Scripps Health

La Jolla, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04636892


Related Trials